Clinical trial / 2006
Zinc supplementation showed mixed effects on cognitive measures at 3 months, with no consistent overall cognitive benefit in healthy older adults.
A randomized, double-blind, placebo-controlled trial evaluated the effects of 0 (placebo), 15, or 30 mg/day of zinc supplementation over 3 and 6 months in 387 healthy adults aged 55-87 years. Younger adults (<70 years) outperformed older adults (>70 years) on all tests. For two out of eight dependent variables, significant interactions were observed: both 15 and 30 mg/day showed a beneficial effect at 3 months only on one measure of spatial working memory, whereas 15 mg/day showed a detrimental effect on one measure of attention. The authors note that further research is needed to determine whether findings apply to older adults in poorer health or with less adequate zinc status.
- Study type
- Randomised double-blind placebo-controlled trial
- Who was studied
- 387 healthy adults aged 55-87 years
- What was measured
- Measures of visual memory, working memory, attention, and reaction time
THE PAPER
Effects of zinc supplementation on cognitive function in healthy middle-aged and older adults: the ZENITH study.
Maylor EA, Simpson EE, Secker DL, Meunier N, Andriollo-Sanchez M, Polito A, Stewart-Knox B, McConville C, O'Connor JM, Coudray C. Br J Nutr, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.